Cardiologie interventionnelle Coronaropathies
JESFC 2023

Angioplastie coronaire

Publié le jeudi 12 janvier 2023

Modérateur(s) :

Jacques Monségu

Orateur(s) :

Philippe Garot , Quentin Landolff , Eric Durand , Antoine Léquipar , Afef Ben Halima , Luc Maillard , Aimen Boughariou

Dans la session

Philippe Garot 2 years outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The Biofreedom France Study
Quentin Landolff Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry
Eric Durand Safety and efficacy of dual vs. triple antithrombotic therapy in patients with indication of anticoagulation treated by PCI: a retrospective analys...
Antoine Léquipar Description and 30-day prognosis of same-day discharge after elective percutaneous coronary intervention in elderly patients: a single-centre registry
Afef Ben Halima Study of cardiovascular comorbidities in ambulatory patients with COVID-19 and their impact on prognosis in the TASC GP study
Luc Maillard How short can we reduce DAPT for HBR patients ? MAPT after COBRA PzF™ NanoCoated Coronary Stent implantation. 200 patients at 1 year

Partager l'article :